Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: World J Urol. 2018 Sep 6;37(12):2623–2629. doi: 10.1007/s00345-018-2477-2

Figure 2.

Figure 2.

The effect of stereotactic ablative radiotherapy on delaying subsequent therapy in men with oligometastatic prostate cancer. (A) Time to next therapy of the entire cohort (blue), HSPC [34] and CRPC (green). (B) Time to ADT initiation in men with oligometastatic HSPC.